Evidence map›Paper›PMID 23888188›Full record

ArticleOncotarget2012

HLX in AML: novel prognostic and therapeutic target.

Ashley Pandolfi, Ulrich Steidl

Open access · hybridAbstract readEditorial
In one paragraph

Article in Oncotarget, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ashley PandolfiDepartment of Cell Biology, Albert Einstein Cancer Center, and Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative MedicineBronx, NY, USA.
Ulrich Steidl
Albert Einstein College of Medicine · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesisF30HL117545 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ECKEL, ASHLEY MARIE · 2013 to 2015
$143k
NHLBI NIH HHS F30 HL117545NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHomeodomain ProteinsHumansLeukemia, Myeloid, AcuteMiceMolecular Targeted TherapyPrognosisTranscription FactorsTreatment OutcomeHLX protein, humanHlx protein, mouseHomeodomain ProteinsTranscription Factors

Identifiers

PMID23888188
PMCPMC3717949
OpenAlexW1591819493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.